Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone vs Placebo for Heart Rate Control in Septic Atrial Fibrillation
NCT03715556Phase 3Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Amiodarone with Placebo (2 arms). Primary endpoint: Complications of safety outcomes at 48 hours. Status: unknown.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03715556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715556.